Why the study?
Does angiography-derived fractional flow reserve compared to intravascular ultrasound improve outcomes in patients with coronary artery disease undergoing PCI for non-complex lesions?
Does angiography-derived fractional flow reserve compared to intravascular ultrasound improve outcomes in patients with coronary artery disease undergoing PCI for non-complex lesions?
Answers are grounded in this paper and cite their sources.
This commentary discusses the FLAVOUR II trial comparing angiography-derived FFR versus IVUS for guiding PCI in non-complex coronary lesions.
This comment refers to ‘Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease (FLAVOUR II): a multicentre, randomised, non-inferiority trial’, published in The Lancet, https://doi.org/10.1016/S0140-6736(25)00504-5. The decision on how to define the indication for revascularization of coronary stenoses and how to optimize the result of PCI is a daily clinical challenge.2 According to the most recent European Society of Cardiology (ESC) guidelines on myocardial revascularization, invasive functional assessment using FFR represents the standard of care for determining the haemodynamic significance of stenosis and guiding the indication for revascularization in patients with CAD [Class I, level of evidence (LoE) A], particularly in case of angiographically intermediate coronary lesions.2 Yet, angiography-derived physiological tools, which allow estimating the functional significance of stenoses without the need for pressure wire or hyperaemic agents, are increasingly being adopted in clinical practice and are supported by current ESC guidelines for the management of patients with CCS (Class I, LoE B).3 On the other hand, while strategies to optimize stent implantation using physiological parameters are emerging, intravascular imaging-based PCI optimization is the gold standard and is currently recommended (Class I, LoE A) in patients with anatomically complex coronary lesions.3
No takes yet. Share an insight, caveat, or question.
Leone et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: